Portfolio Companies

Research     view all

Musculoskeletal News Roundup 8-June-17

June 8, 2017

ASC BioSciences, Trice Medical funding updates...Accelerant Venture acquisition update... Expanding Orthopedics, Medovex Corporation, Bioventures regulatory updates...Exactech, Stryker product introduction and updates... Creative Medical Technology intellectual property updates... Bone Therapeutics completes patient recruitment for trial

Musculoskeletal News Roundup 2-June-17

June 2, 2017

Arthromeda, Hyalex funding updates...OrthoAccel, Orthocell, VEXIM, Zimmer Biomet regulatory updates...K2M, Paragon 28, ProSomnus product introductions and updates...Exactech announces completion of first surgery...Aurora Spine intellectual property updates

OrthoAccel’s New AcceleDent Optima Receives FDA Clearance

June 1, 2017

AcceleDent Optima is the first and only orthodontic device that directly connects patients and practices with usage monitoring, direct messaging and virtual rewards via the state-of-the-art AcceleDent App, which can be downloaded via iTunes and Google Play.

We have invested in more companies in the orthopedic sector than any dedicated healthcare investment firm.
Our team has long standing experience in global markets including active involvement in the rapidly developing Chinese market.
Our teams of musculoskeletal scientific and clinical advisors actively support sourcing and qualifying new technologies and services.
We have key relationships with active strategic acquirers at the CEO level.
Our quest is to find innovative and exciting, emerging and established companies that would benefit from focus, mentorship and investment.
We align our interests with our partners to accelerate growth and create significant value.